A groundbreaking study suggests that bacterial vaginosis (BV), a common vaginal infection that affects nearly one in three women globally, should be reclassified as a sexually transmitted infection (STI). The research, published in The New England Journal of Medicine, revealed that treating both male partners and female patients significantly reduces the recurrence of BV by up to 60%, potentially leading to a shift in medical guidelines for BV treatment.
Currently, BV is primarily viewed as a women’s health issue, but new findings show that addressing the infection in women alone is not enough to prevent reinfection. The study found that when male partners were also treated with antibiotics, the recurrence rate among women dramatically dropped, providing strong evidence that BV may be sexually transmitted.
The Risks of Untreated BV
BV occurs when the delicate balance of bacteria in the vagina is disrupted, leading to symptoms such as itching, unusual discharge, pain during urination, and a fishy odor. However, many women with BV experience no noticeable symptoms at all. If left untreated, BV can result in serious health complications, including an increased risk of HIV and other STIs, as well as pelvic inflammatory disease (PID), which can lead to infertility.
According to Professor Catriona Bradshaw, a senior researcher at the Melbourne Sexual Health Centre, BV causes significant inflammation in the reproductive tract, which can damage vaginal tissues and make it easier for infections to spread, potentially leading to more severe reproductive health issues.
Clinical Trial Reveals New Insights
In an Australian clinical trial involving 164 monogamous couples, researchers tested the impact of treating both female patients and their male partners. The couples were divided into two groups:
The first group received oral antibiotics for both the woman and her male partner, with the men also applying a topical antibiotic to their genital area.
The second group received antibiotics for women only.
The results were striking. Women whose male partners were also treated were 60% less likely to experience reinfection compared to women whose partners were not treated. Lead researcher Lenka Vodstrcil explained, “The bacteria responsible for BV can be found on men, particularly on the skin of the penis and inside the urethra. This suggests that BV is likely sexually transmitted, which explains why so many women experience recurring infections.”
Shifting the Treatment Paradigm
The success of treating both partners prompted researchers to argue that BV should be classified as an STI. This shift would require healthcare providers to inform male partners about their role in reinfection and encourage them to undergo treatment as well. Dr. Christina Muzny and Dr. Jack Sobel, who authored an editorial accompanying the study, stressed that this change would require a shift in mindset, not only for healthcare professionals but also for patients.
“This will require male partners to commit to taking both oral and topical medications once they are informed that their female partner has BV,” they wrote.
Male Partners Show High Treatment Adherence
A concern with the dual-treatment approach was whether men would comply with the prescribed treatment. However, the study found that male participants had no trouble completing their antibiotic course, with no reported side effects that would hinder adherence. Professor Bradshaw noted, “We have treated nearly 300 men with this medication and have had no reports of issues preventing them from completing the treatment.”
Updating Medical Guidelines
In response to the study’s findings, the Melbourne Sexual Health Center has already updated its treatment protocols to include male partners when BV is detected. Additionally, researchers have developed an online resource to help healthcare professionals and couples understand the importance of dual treatment.
“Changing national and international guidelines takes time,” said Bradshaw. “In the meantime, we are providing accessible and accurate information to help people make informed decisions about their health.”
The study’s results could reshape how BV is treated, leading to better outcomes for women and men alike and potentially reducing the risk of infertility and other long-term health complications.
Related topics:
City International Hospital Opens IVF Centre in Ho Chi Minh City
Marty Sheargold Fired Over Controversial Comments on Women’s Health and Sports
Sutter Health Announces Accreditation for Two New OB/Gyn Residency Programs
